BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38340872)

  • 1. Lifestyle-Associated Risk Factors and Gastrointestinal Cancers: Targeting Potential of the Gut Microbe-Host Crosstalk-Based Metabolic Processes.
    Qu R; Zhang Z; Fu W
    Gastroenterology; 2024 Jul; 167(2):419-420. PubMed ID: 38340872
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-bacteria microbiome (virus, fungi, and archaea) in gastrointestinal cancer.
    Coker OO
    J Gastroenterol Hepatol; 2022 Feb; 37(2):256-262. PubMed ID: 34825404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
    Tözün N; Vardareli E
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S191-S196. PubMed ID: 27741173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota in digestive cancers: our new partner?
    Lopez A; Hansmannel F; Kokten T; Bronowicki JP; Melhem H; Sokol H; Peyrin-Biroulet L
    Carcinogenesis; 2017 Dec; 38(12):1157-1166. PubMed ID: 28968883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fat diet, gut microbiome and gastrointestinal cancer.
    Tong Y; Gao H; Qi Q; Liu X; Li J; Gao J; Li P; Wang Y; Du L; Wang C
    Theranostics; 2021; 11(12):5889-5910. PubMed ID: 33897888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.
    Mima K; Kosumi K; Baba Y; Hamada T; Baba H; Ogino S
    Hum Genet; 2021 May; 140(5):725-746. PubMed ID: 33180176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer.
    Marzhoseyni Z; Shaghaghi Z; Alvandi M; Shirvani M
    Curr Cancer Drug Targets; 2024; 24(6):612-628. PubMed ID: 38213140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and disease markers correlate with gut microbiome composition across thousands of people.
    Manor O; Dai CL; Kornilov SA; Smith B; Price ND; Lovejoy JC; Gibbons SM; Magis AT
    Nat Commun; 2020 Oct; 11(1):5206. PubMed ID: 33060586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Western lifestyle as a driver of dysbiosis in colorectal cancer.
    Foegeding NJ; Jones ZS; Byndloss MX
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34060626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota and gastrointestinal cancer.
    Weng MT; Chiu YT; Wei PY; Chiang CW; Fang HL; Wei SC
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S32-S41. PubMed ID: 30655033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning on microbiome research in gastrointestinal cancer.
    Cheung H; Yu J
    J Gastroenterol Hepatol; 2021 Apr; 36(4):817-822. PubMed ID: 33880761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease.
    Askarova S; Umbayev B; Masoud AR; Kaiyrlykyzy A; Safarova Y; Tsoy A; Olzhayev F; Kushugulova A
    Front Cell Infect Microbiol; 2020; 10():104. PubMed ID: 32257964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.
    Cani PD; Jordan BF
    Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):671-682. PubMed ID: 29844585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer.
    Zhang X; Browman G; Siu W; Basen-Engquist KM; Hanash SM; Hoffman KL; Okhuysen PC; Scheet P; Petrosino JF; Kopetz S; Daniel CR
    BMC Cancer; 2019 Dec; 19(1):1233. PubMed ID: 31852462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?
    Ramai D; Salati M; Pomati G; Amoroso C; Facciorusso A; Botticelli A; Ghidini M
    Curr Opin Pharmacol; 2022 Dec; 67():102315. PubMed ID: 36351361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Modulation in the Context of Immune-Related Aspects of
    Kaźmierczak-Siedlecka K; Roviello G; Catalano M; Polom K
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome.
    Martinez JE; Kahana DD; Ghuman S; Wilson HP; Wilson J; Kim SCJ; Lagishetty V; Jacobs JP; Sinha-Hikim AP; Friedman TC
    Front Endocrinol (Lausanne); 2021; 12():667066. PubMed ID: 34168615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease.
    Walker RL; Vlamakis H; Lee JWJ; Besse LA; Xanthakis V; Vasan RS; Shaw SY; Xavier RJ
    Genome Med; 2021 Dec; 13(1):188. PubMed ID: 34915914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host-Microbe Interplay.
    Liu Y; Hou Y; Wang G; Zheng X; Hao H
    Trends Endocrinol Metab; 2020 Nov; 31(11):818-834. PubMed ID: 32284282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.